30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

9 Meters Biopharma Inc (NMTR)

Track

Stock chart
Ticker: NMTR Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
BETHANY SENSENIG
Officer
1 sale — total 2,274 USD
Proposed sale 21 Jul 2023
Value US$3,320,987.20 | Price 251.33 | Shares 57,803
Proposed sale 19 Jul 2023
Value US$3,236,814.59 | Price 257.16 | Shares 49,306
Proposed sale 21 Apr 2023
Value US$12,000.00 | Price 1.26 | Shares 9,500
Sale 21 Apr 2023
Value US$11,011.00 | Price 1.21 | Shares 9,100
Buy 6 Jul 2022
Value US$28,462.50 | Price 0.23 | Shares 125,000
Buy 1 Jul 2022
Value US$42,962.50 | Price 0.25 | Shares 175,000
Buy 23 May 2022
Value US$7,608.00 | Price 0.48 | Shares 16,000
Buy 18 May 2022
Value US$50,000.01 | Price 0.47 | Shares 106,383
Buy 18 May 2022
Value US$22,285.00 | Price 0.45 | Shares 50,000
Buy 3 Mar 2022
Value US$50,002.42 | Price 0.58 | Shares 86,450
Buy 3 Mar 2022
Value US$55,590.00 | Price 0.56 | Shares 100,000
Buy 2 Dec 2021
Value US$44,500.00 | Price 0.89 | Shares 50,000
Buy 18 Nov 2021
Value US$21,200.00 | Price 1.06 | Shares 20,000
Buy 18 Nov 2021
Value US$52,500.00 | Price 1.05 | Shares 50,000
Buy 24 Aug 2021
Value US$20,520.00 | Price 1.14 | Shares 18,000
Buy 5 Apr 2021
Value US$300,000.00 | Price 1.00 | Shares 300,000
Buy 5 Apr 2021
Value US$50,000.00 | Price 1.00 | Shares 50,000
Buy 15 Dec 2020
Value US$99,999.90 | Price 0.65 | Shares 153,846
Buy 15 Dec 2020
Value US$39,999.70 | Price 0.65 | Shares 61,538
Buy 15 Dec 2020
Value US$149,999.85 | Price 0.65 | Shares 230,769
Buy 11 Sep 2020
Value US$14,003.92 | Price 0.65 | Shares 21,485
Buy 11 Sep 2020
Value US$52,360.00 | Price 0.68 | Shares 77,000
Buy 10 Sep 2020
Value US$30,000.00 | Price 0.60 | Shares 50,000
Buy 21 Aug 2020
Value US$48,300.00 | Price 0.69 | Shares 70,000
Buy 20 Aug 2020
Value US$25,581.00 | Price 0.75 | Shares 34,108
Buy 17 Aug 2020
Value US$56,000.00 | Price 0.56 | Shares 100,000
Buy 17 Aug 2020
Value US$19,831.00 | Price 0.57 | Shares 35,000
Buy 15 Jun 2020
Value US$10,720.94 | Price 0.60 | Shares 17,943
Buy 15 Jun 2020
Value US$5,971.00 | Price 0.60 | Shares 10,000
Buy 28 Jun 2019
Value US$4,600.00 | Price 1.15 | Shares 4,000
Buy 13 Jun 2019
Value US$721.02 | Price 1.22 | Shares 591
Buy 13 Jun 2019
Value US$494.89 | Price 1.21 | Shares 409
Buy 30 May 2019
Value US$6,600.00 | Price 1.32 | Shares 5,000
Buy 24 May 2019
Value US$1,280.00 | Price 1.28 | Shares 1,000
Buy 22 May 2019
Value US$6,900.00 | Price 1.38 | Shares 5,000
Buy 30 Nov 2018
Value US$3,682.00 | Price 2.63 | Shares 1,400
Buy 30 Nov 2018
Value US$2,630.00 | Price 2.63 | Shares 1,000
Buy 30 Nov 2018
Value US$2,620.00 | Price 2.62 | Shares 1,000
Buy 30 Nov 2018
Value US$2,640.00 | Price 2.64 | Shares 1,000
Buy 29 Nov 2018
Value US$5,120.00 | Price 2.56 | Shares 2,000
Buy 29 Nov 2018
Value US$2,550.00 | Price 2.55 | Shares 1,000
Buy 29 Nov 2018
Value US$13,750.00 | Price 2.75 | Shares 5,000
Buy 14 Sep 2018
Value US$1,164.00 | Price 5.82 | Shares 200
Buy 12 Sep 2018
Value US$3,065.00 | Price 6.13 | Shares 500
Buy 7 Sep 2018
Value US$3,050.00 | Price 6.10 | Shares 500
Buy 30 Aug 2018
Value US$1,606.80 | Price 5.20 | Shares 309
Buy 30 Aug 2018
Value US$2,620.00 | Price 5.24 | Shares 500
Buy 28 Aug 2018
Value US$4,930.00 | Price 4.93 | Shares 1,000
Buy 28 Aug 2018
Value US$2,057.40 | Price 5.08 | Shares 405
Buy 28 Aug 2018
Value US$481.65 | Price 5.07 | Shares 95
Buy 28 Aug 2018
Value US$1,220.00 | Price 4.88 | Shares 250
Buy 28 Aug 2018
Value US$0.00 | Price 4.90 | Shares 0
Buy 27 Aug 2018
Value US$494.00 | Price 4.94 | Shares 100
Buy 27 Aug 2018
Value US$1,254.88 | Price 4.96 | Shares 253
Buy 27 Aug 2018
Value US$230.30 | Price 4.90 | Shares 47
Buy 24 Aug 2018
Value US$2,425.00 | Price 4.85 | Shares 500
Buy 24 Aug 2018
Value US$1,996.00 | Price 4.99 | Shares 400
Buy 24 Aug 2018
Value US$485.00 | Price 4.85 | Shares 100
Buy 26 Jan 2018
Value US$105,000.00 | Price 0.35 | Shares 300,000
Buy 29 Nov 2017
Value US$164,771.55 | Price 0.45 | Shares 366,159
Buy 23 Jun 2017
Value US$100,000.12 | Price 0.58 | Shares 172,414
Buy 16 Mar 2017
Value US$105,000.00 | Price 1.50 | Shares 70,000
Buy 13 Jul 2016
Value US$67,500.00 | Price 4.50 | Shares 15,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-07-21 2023-07-21 PrS Proposed sale
3.4
BETHANY SENSENIG

Officer

Officer
57,803
251.33
US$3,320,987 		57,803 251.33 US$3,320,987
2023-07-19 2023-07-19 PrS Proposed sale
3.6
Sirgo Mark A

Director

Non-Executive Director
49,306
257.16
US$3,236,815 		49,306 257.16 US$3,236,815
2023-04-21 2023-04-21 PrS Proposed sale
3.4
Bethany L. Sensenig

Officer

Officer
1,045
283.71
US$653,560 		1,045 283.71 US$653,560
2023-04-21 2023-04-21 S Sale
3.4
Sensenig Bethany

Chief Financial Officer

Officer
9,100 -18.1%
1.21
US$11,011 		9,100 -18.1% 1.21 US$11,011
2022-07-08 2022-07-06 B Purchase
Temperato John

Chief Executive Officer

Executive Director
125,000 +9.6%
0.23
US$28,462 		125,000 +9.6% 0.23 US$28,462
2022-07-06 2022-07-01 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
175,000 +13.7%
0.25
US$42,962 		175,000 +13.7% 0.25 US$42,962
2022-05-24 2022-05-23 B Purchase
2.2
Constantino Michael T.
Non-Executive Director
16,000 +35.9%
0.48
US$7,608 		16,000 +35.9% 0.48 US$7,608
2022-05-19 2022-05-18 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
106,383 +8.3%
0.47
US$50,000 		106,383 +8.3% 0.47 US$50,000
2022-05-19 2022-05-18 B Purchase
Temperato John

Chief Executive Officer

Executive Director
50,000 +4.0%
0.45
US$22,285 		50,000 +4.0% 0.45 US$22,285
2022-03-07 2022-03-03 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
86,450 +7.2%
0.58
US$50,002 		86,450 +7.2% 0.58 US$50,002
2022-03-04 2022-03-03 B Purchase
Temperato John

Chief Executive Officer

Executive Director
100,000 +8.7%
0.56
US$55,590 		100,000 +8.7% 0.56 US$55,590
2021-12-03 2021-12-02 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
50,000 +4.2%
0.89
US$44,500 		50,000 +4.2% 0.89 US$44,500
2021-11-22 2021-11-18 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
20,000 +1.7%
1.06
US$21,200 		20,000 +1.7% 1.06 US$21,200
2021-11-19 2021-11-18 B Purchase
Temperato John

Chief Executive Officer

Executive Director
50,000 +4.5%
1.05
US$52,500 		50,000 +4.5% 1.05 US$52,500
2021-08-26 2021-08-24 B Purchase
2.2
Constantino Michael T.
Non-Executive Director
18,000 +52.8%
1.14
US$20,520 		18,000 +52.8% 1.14 US$20,520
2021-04-06 2021-04-05 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
300,000 +38.8%
1.00
US$300,000 		300,000 +38.8% 1.00 US$300,000
2021-04-06 2021-04-05 B Purchase
Sitar Edward J

Chief Financial Officer

Officer
50,000 +38.7%
1.00
US$50,000 		50,000 +38.7% 1.00 US$50,000
2020-12-17 2020-12-15 B Purchase
Temperato John

Chief Executive Officer

Executive Director
153,846 +18.7%
0.65
US$100,000 		153,846 +18.7% 0.65 US$100,000
2020-12-17 2020-12-15 B Purchase
Sitar Edward J

Chief Financial Officer

Officer
61,538 +90.8%
0.65
US$40,000 		61,538 +90.8% 0.65 US$40,000
2020-12-17 2020-12-15 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
230,769 +42.5%
0.65
US$150,000 		230,769 +42.5% 0.65 US$150,000
2020-09-14 2020-09-11 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
21,485 +inf%
0.65
US$14,004 		21,485 +inf% 0.65 US$14,004
2020-09-14 2020-09-11 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
77,000 +16.7%
0.68
US$52,360 		77,000 +16.7% 0.68 US$52,360
2020-09-14 2020-09-10 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
50,000 +12.1%
0.60
US$30,000 		50,000 +12.1% 0.60 US$30,000
2020-08-24 2020-08-21 B Purchase
Temperato John

Chief Executive Officer

Executive Director
70,000 +12.8%
0.69
US$48,300 		70,000 +12.8% 0.69 US$48,300
2020-08-21 2020-08-20 B Purchase
2.2
Constantino Michael T.
Non-Executive Director
34,108 +inf%
0.75
US$25,581 		34,108 +inf% 0.75 US$25,581
2020-08-18 2020-08-17 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
100,000 +32.1%
0.56
US$56,000 		100,000 +32.1% 0.56 US$56,000
2020-08-17 2020-08-17 B Purchase
Temperato John

Chief Executive Officer

Executive Director
35,000 +6.9%
0.57
US$19,831 		35,000 +6.9% 0.57 US$19,831
2020-06-16 2020-06-15 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
17,943 +45.5%
0.60
US$10,721 		17,943 +45.5% 0.60 US$10,721
2020-06-15 2020-06-15 B Purchase
Temperato John

Chief Executive Officer

Executive Director
10,000 +25.4%
0.60
US$5,971 		10,000 +25.4% 0.60 US$5,971
2019-07-01 2019-06-28 B Purchase
3.3
Laumas Sandeep

CEO, Executive Chairman

Executive Director
4,000 +28.6%
1.15
US$4,600 		4,000 +28.6% 1.15 US$4,600
2019-06-17 2019-06-13 B Purchase
3.3
Laumas Sandeep

CEO, Executive Chairman

Executive Director
591 +4.4%
1.22
US$721 		591 +4.4% 1.22 US$721
2019-06-17 2019-06-13 B Purchase
3.3
Laumas Sandeep

CEO, Executive Chairman

Executive Director
409 +3.1%
1.21
US$495 		409 +3.1% 1.21 US$495
2019-06-03 2019-05-30 B Purchase
Madan Jay P.

President

Executive Director
5,000 +6.3%
1.32
US$6,600 		5,000 +6.3% 1.32 US$6,600
2019-05-28 2019-05-24 B Purchase
Proujansky Roy
1,000 +71.4%
1.28
US$1,280 		1,000 +71.4% 1.28 US$1,280
2019-05-23 2019-05-22 B Purchase
3.3
Laumas Sandeep

CEO, Executive Chairman

Executive Director
5,000 +62.5%
1.38
US$6,900 		5,000 +62.5% 1.38 US$6,900
2018-12-03 2018-11-30 B Purchase Proujansky Roy Non-Executive Director
1,400 +inf%
2.63
US$3,682 		1,400 +inf% 2.63 US$3,682
2018-12-03 2018-11-30 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
1,000 +14.3%
2.63
US$2,630 		1,000 +14.3% 2.63 US$2,630
2018-12-03 2018-11-30 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
1,000 +16.7%
2.62
US$2,620 		1,000 +16.7% 2.62 US$2,620
2018-12-03 2018-11-30 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
1,000 +20.0%
2.64
US$2,640 		1,000 +20.0% 2.64 US$2,640
2018-11-29 2018-11-29 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
2,000 +66.7%
2.56
US$5,120 		2,000 +66.7% 2.56 US$5,120
2018-11-29 2018-11-29 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
1,000 +50.0%
2.55
US$2,550 		1,000 +50.0% 2.55 US$2,550
2018-11-29 2018-11-29 B Purchase Prior Christopher P.

Chief Executive Officer

Executive Director
5,000 +248.9%
2.75
US$13,750 		5,000 +248.9% 2.75 US$13,750
2018-09-14 2018-09-14 B Purchase Prior Christopher P.

Chief Executive Officer

Executive Director
200 +11.1%
5.82
US$1,164 		200 +11.1% 5.82 US$1,164
2018-09-13 2018-09-12 B Purchase Prior Christopher P.

Chief Executive Officer

Executive Director
500 +38.2%
6.13
US$3,065 		500 +38.2% 6.13 US$3,065
2018-09-10 2018-09-07 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
500 +33.3%
6.10
US$3,050 		500 +33.3% 6.10 US$3,050
2018-08-30 2018-08-30 B Purchase Prior Christopher P.

Chief Executive Officer

Executive Director
309 +30.9%
5.20
US$1,607 		309 +30.9% 5.20 US$1,607
2018-08-30 2018-08-30 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
500 +200.0%
5.24
US$2,620 		500 +200.0% 5.24 US$2,620
2018-08-28 2018-08-28 B Purchase Prior Christopher P.

Chief Executive Officer

Executive Director
1,000 +inf%
4.93
US$4,930 		1,000 +inf% 4.93 US$4,930
2018-08-28 2018-08-28 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
405 +68.1%
5.08
US$2,057 		405 +68.1% 5.08 US$2,057
2018-08-28 2018-08-28 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
95 +19.0%
5.07
US$482 		95 +19.0% 5.07 US$482
2018-08-28 2018-08-28 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
250 +100.0%
4.88
US$1,220 		250 +100.0% 4.88 US$1,220
2018-08-28 2018-08-28 B Purchase Laumas Sandeep

Executive Chairman

Executive Director
0
4.90
US$0 		0 4.90 US$0
2018-08-28 2018-08-27 B Purchase Almenoff June Sherie

COO and Chief Medical Officer

Officer
100 +12.5%
4.94
US$494 		100 +12.5% 4.94 US$494
2018-08-28 2018-08-27 B Purchase Almenoff June Sherie

COO and Chief Medical Officer

Officer
253 +46.3%
4.96
US$1,255 		253 +46.3% 4.96 US$1,255
2018-08-28 2018-08-27 B Purchase Almenoff June Sherie

COO and Chief Medical Officer

Officer
47 +9.4%
4.90
US$230 		47 +9.4% 4.90 US$230
2018-08-28 2018-08-24 B Purchase Almenoff June Sherie

COO and Chief Medical Officer

Officer
500 +55.6%
4.85
US$2,425 		500 +55.6% 4.85 US$2,425
2018-08-28 2018-08-24 B Purchase Almenoff June Sherie

COO and Chief Medical Officer

Officer
400 +400.0%
4.99
US$1,996 		400 +400.0% 4.99 US$1,996
2018-08-28 2018-08-24 B Purchase Almenoff June Sherie

COO and Chief Medical Officer

Officer
100 +inf%
4.85
US$485 		100 +inf% 4.85 US$485
2018-03-13 2018-01-26 B Purchase CLARKE DAVID H

Former CEO and Director

Executive Director
300,000 +21.1%
0.35
US$105,000 		300,000 +21.1% 0.35 US$105,000
2018-03-13 2017-11-29 B Purchase CLARKE DAVID H

Former CEO and Director

Executive Director
366,159 +36.3%
0.45
US$164,772 		366,159 +36.3% 0.45 US$164,772
2018-03-13 2017-06-23 B Purchase CLARKE DAVID H

Former CEO and Director

Executive Director
172,414 +25.0%
0.58
US$100,000 		172,414 +25.0% 0.58 US$100,000
2018-03-13 2017-03-16 B Purchase CLARKE DAVID H

Former CEO and Director

Executive Director
70,000 +11.3%
1.50
US$105,000 		70,000 +11.3% 1.50 US$105,000
2018-03-13 2016-07-13 B Purchase CLARKE DAVID H

Former CEO and Director

Executive Director
15,000 +3.5%
4.50
US$67,500 		15,000 +3.5% 4.50 US$67,500
Explore more

More insider trading research around 9 Meters Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America